LNCaP-SF was established after long-term cultivation of LNCaP in steroid-free conditions, and LN-Pre and LN-REC4 were established from LNCaP inoculated in intact and castrated severe combined immunodeficient mice, respectively. Uptake and competitive inhibition experiments were performed with trans-1-amino-3-fluoro[1-14C]cyclobutanecarboxylic acid ([14C]fluciclovine) to characterize the involvement of AATs in androgen-dependent PCa (LNCaP and LN-Pre) and CRPC-like (LNCaP-SF and LN-REC4) cell lines. AAT expression was analyzed by Western blotting, and [14C]fluciclovine uptake in androgen-dependent PCa and CRPC-like cell lines were investigated in the presence or absence of dihydrotestosterone (DHT).
The contribution of Na+-dependent AATs to [14C]fluciclovine uptake in all cell lines was 88−98%, and [14C]fluciclovine uptake was strongly inhibited by l-glutamine and l-serine, the substrates for Na+-dependent alanine-serine-cysteine (system ASC) AATs, in the presence of Na+. DHT enhanced ASCT2 expression in LNCaP, LN-Pre, and LN-REC4, but not in LNCaP-SF, and the responses of ASCT2 expression to DHT correlated with [14C]fluciclovine uptake.
System ASC, especially ASCT2, could play a major role in [14C]fluciclovine uptake into CRPC-like and androgen-dependent PCa cells, suggesting [18F]fluciclovine-PET is applicable to the detection of CRPC as well as androgen-dependent PCa.
[18F]fluciclovine-PET may be applied for the detection of CRPC.
[18F]fluciclovine-PET may permit early intervention for CRPC treatment.